EUVIMEDEUVIMED entdecken
EditorialOpen Access

Inherited retinal diseases and gene therapy update

Arif O Khan

Saudi Journal of Ophthalmology · 2023-10 · 37 (4) · 261-262

DOI: 10.4103/sjopt.sjopt_295_23 ↗

Kurz gefasst

Editorial in der Zeitschrift Saudi Journal of Ophthalmology, online erschienen am 21.12.2023. Verfasst von Arif O Khan. Beteiligte Einrichtung: Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited retinal diseases (IRDs) are a phenotypically and genotypically diverse group of typically monogenic disorders. Collectively, the worldwide average prevalence is estimated at one case per 1380 individuals,[1] but IRDs are more common in certain regions of the world, such as the Middle East.[2] IRD classification is based on affected retinal cell types, age of onset, and progression. Clinical diagnoses include Leber congenital amaurosis, early-onset retinal dystrophy, cone-rod dystrophy, rod-cone dystrophy (which includes classic retinitis pigmentosa), macular dystrophy, vitreoretinopathy, congenital stationary night blindness, and achromatopsia. IRDs can be isolated eye disease or part of a multi-system disorder. Inheritance can be autosomal dominant, autosomal recessive, X-linked, or mitochondrial. We are currently in an era of preimplantation diagnosis, gene therapy, and gene therapy trials. It is thus more important than ever to accurately diagnosis and counsel affected patients and their families. This special issue of the Saudi Journal of Ophthalmology highlights the field of inherited retinal disease and gene therapy. Of the four review articles in this special issue,[3-6] two provide overviews on special topics[3,4] and two each highlight a specific retinal disease gene and the potential for therapy.[5,6] “Full-field electroretinography (ERG) – when do we need it?”[3] reviews the utility and indications for ERG in clinical practice. “Pediatric retinal vascular disorders: From translational sciences to clinical practice”[4] provides a theoretical framework for understanding the pathogenesis of pediatric retinal vascular disease. The article on RPGR-related retinopathy[5] reviews the molecular biology, clinical manifestations, and recent progress of gene therapy clinical trials for this often underdiagnosed cause of retinal dystrophy in boys.[6] The article on BEST1-related retinopathy[7] discusses how the clinical and molecular features of this group of disorders (bestrophinopathies) are much more than that of classic autosomal dominant Best macular dystrophy and how these features are being used to design therapeutic strategies. Three clinical articles from Saudi Arabia[8-10] and one from the United Arab Emirates[11] share experiences and observations from the region. An ocular genetic counseling study from Riyadh[8] reports the experience with ocular genetic counseling at a referral eye hospital as well as the challenges. A study of achromatopsia from Jeddah[9] notes a founder mutation for the region. A small case series of Alström syndrome from Riyadh[10] describes phenotypic and genotypic observations. A case report from Abu Dhabi[11] highlights how infantile retinal dystrophy can herald later systemic disease and that visual loss in a retinal dystrophy patient can be from causes other than the retinal dystrophy itself. The final article in this issue describes a visually-guided swim assay for the assessment of functional vision in IRD mouse models.[12] It is an example of the type of preclinical work necessary for IRD therapy development.

Autor:innen und Institutionen

  • Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.

Zitieren

APA

Khan, A. O. (2023). Inherited retinal diseases and gene therapy update. Saudi Journal of Ophthalmology, 37(4), 261-262. https://doi.org/10.4103/sjopt.sjopt_295_23

Vancouver

Khan AO. Inherited retinal diseases and gene therapy update. Saudi Journal of Ophthalmology. 2023;37(4):261-262. doi:10.4103/sjopt.sjopt_295_23

BibTeX
@article{Khan2023,
  author = {Khan, Arif O},
  title = {Inherited retinal diseases and gene therapy update},
  journal = {Saudi Journal of Ophthalmology},
  year = {2023},
  volume = {37},
  number = {4},
  pages = {261--262},
  doi = {10.4103/sjopt.sjopt_295_23}
}
Kostenlos starten →